Common Variable Immunodeficiency Disorders as a Model for Assessing COVID-19 Vaccine Responses in Immunocompromised Patients

Front Immunol. 2022 Jan 18:12:798389. doi: 10.3389/fimmu.2021.798389. eCollection 2021.

Rohan Ameratunga^{1

2

3}, See-Tarn Woon^{2

3}, Richard Steele^{2

4}, Klaus Lehnert^{5

6}, Euphemia Leung^{6

7}, Emily S J Edwards⁸, Anna E S Brooks^{5

6}

¹ Department of Clinical Immunology, Auckland Hospital, Auckland, New Zealand.
² Department of Virology and Immunology, Auckland Hospital, Auckland, New Zealand.
³ Department of Molecular Medicine and Pathology, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
⁴ Department of Respiratory Medicine, Wellington Hospital, Wellington, New Zealand.
⁵ School of Biological Sciences, University of Auckland, Auckland, New Zealand.
⁶ Maurice Wilkins Centre, School of Biological Sciences, University of Auckland, Auckland, New Zealand.
⁷ Auckland Cancer Society Research Centre, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
⁸ Allergy and Clinical Immunology Laboratory, Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia.

No abstract available

Keywords: COVID-19; CVID - common variable immunodeficiency disorders; SARS-CoV-2; antibody deficiency; vaccine responses.

MeSH terms